BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 10226761)

  • 1. Peripheral cardiovascular actions of SR 58611 A, a beta 3-adrenoceptor agonist, in the dog: lack of central effect.
    Montastruc JL; Verwaerde P; Pelat M; Galitzky J; Langin D; Lafontan M; Berlan M
    Fundam Clin Pharmacol; 1999; 13(2):180-6. PubMed ID: 10226761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High isoproterenol doses are required to activate beta3-adrenoceptor-mediated functions in dogs.
    Pelat M; Verwaerde P; Galitzky J; Lafontan M; Berlan M; Senard JM; Montastruc JL
    J Pharmacol Exp Ther; 2003 Jan; 304(1):246-53. PubMed ID: 12490598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Further evidence for differences between cardiac atypical beta-adrenoceptors and brown adipose tissue beta3-adrenoceptors in the pithed rat.
    Malinowska B; Schlicker E
    Br J Pharmacol; 1997 Dec; 122(7):1307-14. PubMed ID: 9421276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-3 adrenoceptor-mediated increase in cutaneous blood flow in the dog.
    Berlan M; Galitzky J; Bousquet-Melou A; Lafontan M; Montastruc JL
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1444-51. PubMed ID: 7908057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular effects of beta 3-adrenoceptor stimulation in perinephritic hypertension.
    Donckier JE; Massart PE; Van Mechelen H; Heyndrickx GR; Gauthier C; Balligand JL
    Eur J Clin Invest; 2001 Aug; 31(8):681-9. PubMed ID: 11473569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of propranolol-sensitive beta-adrenoceptor signaling after inhibition of nitric oxide synthesis.
    Whalen EJ; Bates JN; Johnson AK; Lewis SJ
    Br J Pharmacol; 2006 Apr; 147(7):755-64. PubMed ID: 16474417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta 3-adrenoceptor stimulation induces vasorelaxation mediated essentially by endothelium-derived nitric oxide in rat thoracic aorta.
    Trochu JN; Leblais V; Rautureau Y; Bévérelli F; Le Marec H; Berdeaux A; Gauthier C
    Br J Pharmacol; 1999 Sep; 128(1):69-76. PubMed ID: 10498836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodynamic and neural mechanisms of action of thyrotropin-releasing hormone in the rat.
    Sirén AL; Lake CR; Feuerstein G
    Circ Res; 1988 Jan; 62(1):139-54. PubMed ID: 2891452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of beta-adrenoceptor agonists on the pulmonary circulation. Effects of a beta3-adrenoceptor antagonist, SR 59230A.
    Dumas M; Dumas JP; Bardou M; Rochette L; Advenier C; Giudicelli JF
    Eur J Pharmacol; 1998 May; 348(2-3):223-8. PubMed ID: 9652337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences between the third cardiac beta-adrenoceptor and the colonic beta 3-adrenoceptor in the rat.
    Kaumann AJ; Molenaar P
    Br J Pharmacol; 1996 Aug; 118(8):2085-98. PubMed ID: 8864547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular effects of rat calcitonin gene-related peptide in the conscious rat.
    Sirén AL; Feuerstein G
    J Pharmacol Exp Ther; 1988 Oct; 247(1):69-78. PubMed ID: 2459371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mediation of the positive chronotropic effect of CGP 12177 and cyanopindolol in the pithed rat by atypical beta-adrenoceptors, different from beta 3-adrenoceptors.
    Malinowska B; Schlicker E
    Br J Pharmacol; 1996 Mar; 117(5):943-9. PubMed ID: 8851515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cardiovascular effects of ICI 118,587: A beta 1-adrenoceptor partial agonist.
    Nuttall A; Snow HM
    Br J Pharmacol; 1982 Oct; 77(2):381-8. PubMed ID: 6128041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coexistence of beta 1-, beta 2-, and beta 3-adrenoceptors in dog fat cells and their differential activation by catecholamines.
    Galitzky J; Reverte M; Portillo M; Carpéné C; Lafontan M; Berlan M
    Am J Physiol; 1993 Mar; 264(3 Pt 1):E403-12. PubMed ID: 8096365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central and peripheral alpha-adrenoceptor number and responsiveness after sinoaortic denervation in the rabbit.
    Berthelot A; Hamilton CA; Petty MA; Reid JL
    J Cardiovasc Pharmacol; 1982; 4(4):567-74. PubMed ID: 6181330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central alpha 1- and alpha 2-adrenoceptors and brain cholinergic stimulation in sinoaortic denervated rats.
    Taira CA; Enero MA
    Eur J Pharmacol; 1994 Dec; 271(1):9-16. PubMed ID: 7698216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effects of SR 58611A on canine colonic motility: evidence for a role of beta 3-adrenoceptors.
    De Ponti F; Cosentino M; Costa A; Girani M; Gibelli G; D'Angelo L; Frigo G; Crema A
    Br J Pharmacol; 1995 Apr; 114(7):1447-53. PubMed ID: 7606348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of force--frequency relation during AV-block, sinus node block and beta-adrenoceptor block in conscious animals.
    De Pauw M; Vilaine JP; Heyndrickx GR
    Basic Res Cardiol; 2004 Sep; 99(5):360-71. PubMed ID: 15338245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro inhibition of human colonic motility with SR 59119A and SR 59104A: evidence of a beta3-adrenoceptor-mediated effect.
    Bardou M; Dousset B; Deneux-Tharaux C; Smadja C; Naline E; Chaput JC; Naveau S; Manara L; Croci T; Advenier C
    Eur J Pharmacol; 1998 Jul; 353(2-3):281-7. PubMed ID: 9726658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular actions of dopexamine in anaesthetized and conscious dogs.
    Einstein R; Abdul-Hussein N; Wong TW; Chang DH; Matthews R; Richardson DP
    Br J Pharmacol; 1994 Jan; 111(1):199-204. PubMed ID: 7912154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.